> ## Content Index
> Fetch the complete content index at: https://news.arxhq.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Entera closes $10 million BVF-led direct investment, with up to $24.5 million potential
- URL: https://news.arxhq.com/entera-10m-bvf-direct/
- Published: 2026-04-02T16:00:00.000Z
- Updated: 2026-09-08T11:28:25.000Z
- Description: NASDAQ: ENTX. A vote of confidence ahead of the EB613 Phase 3 registration study.
- Author: Arx Staff
- Tags: Client news, Deals

A significant milestone for Entera Bio Ltd. (NASDAQ: ENTX).

Entera successfully closed a $10 million direct investment led by BVF Partners, a leading institutional healthcare fund, with total potential proceeds of up to $24.5 million.

This is more than capital. It is a vote of confidence. The financing is expected to support initiation of Entera’s Phase 3 registration study for EB613, a critical step toward potential commercialization and a broader shift in how peptide therapies are delivered.

[Read the full release](https://investors.enterabio.com/news-releases/news-release-details/entera-bio-announces-pricing-100-million-direct-investment-bvf?ref=news.arxhq.com)